We are live on ! Find out more
LAB icon

Standard BioTools
LAB

135 hedge funds and large institutions have $864M invested in Standard BioTools in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

26% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 43

8.48% more ownership

Funds ownership: 93.19% → 101.67% (+8.5%)

3% more funds holding

Funds holding: 131 → 135 (+4)

1% more capital invested

Capital invested by funds: $854M → $864M (+$10.1M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

97% less call options, than puts

Call options by funds: $6K | Put options by funds: $196K

Holders
135
Holders Change
+4
Holders Change %
+3.05%
% of All Funds
2.93%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
29
Increased
54
Reduced
43
Closed
23
Calls
$6K
Puts
$196K
Net Calls
-$190K
Net Calls Change
-$452K

Top Buyers

1
BlackRock
BlackRock
New York
+$29.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$21.8M
3
Morgan Stanley
Morgan Stanley
New York
+$19M
4
N
Nuveen
North Carolina
+$14.3M
5
State Street
State Street
Massachusetts
+$9.18M

Top Sellers

1
EIP
Easterly Investment Partners
Massachusetts
-$18.2M
2
Deutsche Bank
Deutsche Bank
Germany
-$10.7M
3
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$9.3M
4
SSA
Schonfeld Strategic Advisors
New York
-$7.08M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
26
ClariVest Asset Management
California
$7.5M -$58.6K -4,600 -0.7%
Schroder Investment Management Group
27
Schroder Investment Management Group
United Kingdom
$7.45M +$2.6M +203,862 +51%
SSA
28
Schonfeld Strategic Advisors
New York
$7.35M -$7.08M -555,900 -48%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$7.04M +$292K +22,898 +4%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$6.76M -$4.9M -384,683 -41%
Northern Trust
31
Northern Trust
Illinois
$6.62M +$592K +46,480 +9%
SG Americas Securities
32
SG Americas Securities
New York
$5.36M +$5.54M +435,032 New
Artisan Partners
33
Artisan Partners
Wisconsin
$5.14M +$2.02M +158,827 +61%
KCM
34
Kennedy Capital Management
Missouri
$4.55M +$4.52K +355 +0.1%
Deutsche Bank
35
Deutsche Bank
Germany
$4.45M -$10.7M -838,854 -70%
Wells Fargo
36
Wells Fargo
California
$4.16M +$1.26M +99,137 +42%
AQR Capital Management
37
AQR Capital Management
Connecticut
$4.07M +$1.47M +115,156 +53%
AllianceBernstein
38
AllianceBernstein
Tennessee
$3.86M +$2.96M +232,050 +286%
OAM
39
Oxford Asset Management
United Kingdom
$3.83M -$181K -14,243 -4%
Goldman Sachs
40
Goldman Sachs
New York
$3.75M +$1.09M +85,309 +39%
MSL
41
Mackay Shields LLC
New York
$3.73M +$2.36M +185,378 +158%
PCM
42
Perkins Capital Management
Minnesota
$3.67M -$425K -33,350 -10%
NCGI
43
Next Century Growth Investors
Minnesota
$3.56M -$35K -2,750 -0.9%
CM
44
Castleark Management
Illinois
$3.36M +$378K +29,695 +12%
CCM
45
Cadence Capital Management
Massachusetts
$3.27M +$1.56M +122,674 +86%
PVI
46
Pura Vida Investments
New York
$2.96M -$2.29M -180,000 -43%
Fuller & Thaler Asset Management
47
Fuller & Thaler Asset Management
California
$2.75M -$16.3K -1,280 -0.6%
EI
48
EAM Investors
California
$2.72M -$2.11M -165,772 -43%
FA
49
Friess Associates
Delaware
$2.38M +$2.46M +193,100 New
AC
50
Alexandria Capital
Virginia
$2.33M – – –
1
2
3 4 5

LAB Hedge Fund Activity: Q2 2019 in Review

135 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2019, worth a combined $864M — up 1.2% from $854M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new LAB positions and 23 closed out — a net gain of 6 holders — while 54 added to existing stakes and 43 trimmed.

The largest buyer was BlackRock, adding an estimated $29.2M. The largest seller was Easterly Investment Partners, cutting an estimated $18.2M.

  • 135 institutional investors held Standard BioTools (LAB) as of Q2 2019, up from 131 in Q1 2019.
  • Funds reported $864M of Standard BioTools stock for Q2 2019, up 1.2% quarter-over-quarter.
  • 29 funds opened new Standard BioTools positions in Q2 2019 and 23 closed out, a net change of +6 holders.
  • The largest Standard BioTools buyer in Q2 2019 was BlackRock, an estimated $29.2M added.
  • The largest Standard BioTools seller in Q2 2019 was Easterly Investment Partners, an estimated $18.2M sold.

Based on aggregated 13F filings for Q2 2019.